Obermatt
See Similar Stocks →

SOPHiA GENETICS

NSQ:SOPH · CH1125843347
Health Care TechnologySmall

360

52
Profit price59
Owner Earnings Yield1
Dividend Yield1
Price/Sales13
EV / Gross Profit29
Price/Book100
Return on Capital5
Cash Return on Capital1
Return on Equity8
EBIT Margin7
Gross Profitability49
Accruals87
Owner Earnings Margin8
Sales growth92
Profit growth41
Reinvestment15
Price momentum94
Debt load13
Refinancing30
Debt Payback1
Liquidity6
Analyst ratings100
Opinion Changes50
Price Target Upside67
Market mood55
Value Creation6/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

SOPHiA GENETICS doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountrySwitzerland
IndustryHealth Care Technology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2011
Employees481
Websitesophiagenetics.com
ISINCH1125843347
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Machine LearningCloud InfrastructurePredictive AnalyticsCloud Data ServicesArtificial IntelligenceDevSecOpsHealth DiagnosticsGeneticsSoftware DevelopmentOncologyBig DataBioinformaticsBiotechnologyHealth CareLife ScienceMedical

Description

SOPHiA GENETICS SA (‘SOPHiA GENETICS’) operates as a cloud-native software technology company in the healthcare space dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. The company…

Analysis

Weak and unloved

SOPHiA GENETICS SA scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is solid; the safety picture is adequate. The company scores 6/20 on our value-creation score: not creating value. Analysts lean positive.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
50
2023202420252026

All-time high

90

Jan 2024

All-time low

25

Jan 2023

Average rank

50

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
13
29
25
5
Price/Earnings
97
77
77
21
Price/Book
100
53
77
67
Dividend Yield
1
1
1
1
Value (overall)
39
31
45
23

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare SOPHiA GENETICS with its peers
Planisware
PAR:PLNW
69
CountryFrance
IndustrySoftware
SizeSmall
Full Stock Analysis →
Kainos Group
LSE:KNOS
98
CountryUK
IndustryIT Services
SizeSmall
Full Stock Analysis →
Ceragon Networks
NSQ:CRNT
56
CountryIsrael
IndustryCommunications Equipment
SizeSmall
Full Stock Analysis →
NCC
LSE:NCC
4
CountryUK
IndustryIT Services
SizeSmall
Full Stock Analysis →
Opera
NSQ:OPRA
93
CountryNorway
IndustrySoftware
SizeMedium
Full Stock Analysis →
Galapagos
AEX:GLPG
76
CountryBelgium
IndustryBiotechnology
SizeMedium
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →